| R2032610 |
ORG27569 |
Org 27569 is a potent CB1 receptor allosteric modulator, which increases agonist
|
| R2032611 |
NVP-231 |
NVP-231 is a potent, specific, and reversible CerK inhibitor(IC50=12±2 nM) that
|
| R2032612 |
b-AP15;NSC 687852) |
b-AP15 is a specific inhibitor of the deubiquitinating enzymes UCHL5 and Usp14.
|
| R2032613 |
AZ5104 |
AZ-5104 is an active, demethylated metabolite of AZD 9291.AZ-5104 is an EGFR inh
|
| R2032614 |
Cathepsin S inhibitor |
LY 3000328 is a potent and selective Cathepsin S (Cat S) inhibitor with IC50s of
|
| R2032615 |
GSK1014802(CNV1014802) |
Raxatrigine (GSK-1014802) is a novel small molecule state-dependent sodium chann
|
| R2032616 |
GSK503 |
GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Ki
|
| R2032617 |
GSK650394 |
GSK 650394 is a novel SGK inhibitor with IC50 of 62 nM and 1
|
| R2032618 |
INCB032304 |
INCB032304 is a pharmaceutical intermediate.
|
| R2032619 |
KRCA-0008 |
KRCA-0008 is a potent and selective ALK/Ack1 inhibitor with IC50 of 12 nM/4 nM f
|
| R2032620 |
LY2484595 |
Evacetrapib is a potent and selective of CETP inhibitor, which inhibits human re
|
| R2032621 |
RGB-286638 |
RGB-286638 is a CDK inhibitor that inhibits the kinase activity of cyclin T1-CDK
|
| R2032622 |
TG003 |
TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50
|
| R2032623 |
Thiamet G |
Thiamet G is a potent and selective inhibitor of O-GlcNAcase (OGA), which acts t
|
| R2032624 |
UNC0642 |
UNC0642 is a potent and selective G9a/GLP inhibitor, with an IC50 of less than 2
|
| R2032625 |
z-devd-fmk |
Z-DEVD-FMK is a specific and irreversible caspase-3 inhibitor with IC50 of 18 μM
|
| R2032626 |
BMS663068;Fostemsavir(BMS-663068) |
Fostemsavir (BMS-663068) is the phosphonooxymethyl prodrug of BMS-626529.Fostems
|
| R2032627 |
BX517(PDK1 inhibitor2) |
BX517 is a potent and selective inhibitor of PDK1 with IC50 of 6 nM.
|
| R2032628 |
Darapladib(SB-480848) |
Darapladib is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-
|
| R2032629 |
GDC-0349 |
GDC-0349 is a potent and selective ATP-competitive mTOR inhibitor with a Ki of 3
|
| R2032630 |
GSK-J4 |
GSK-J4 is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and U
|
| R2032631 |
GSK2838232 |
|
| R2032632 |
KN-92 hydrochloride |
KN-92 hydrochloride is an inactive derivative of KN-93.KN-93 is a selective inhi
|
| R2032633 |
KNK437 |
KNK437 is a HSP inhibitor, and inhibits the induction of HSP105, HSP70, and HSP4
|
| R2032634 |
Cligosiban(PF-3274167) |
Cligosiban (PF-3274167), a high oral bioavailability and good brain-penetrant no
|